Biggest News Aggregation in the World
๐Ÿ“ฐ Access Program News

Page 172 - Access Program News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Access Program. Real-time updates on events, politics, business and more.

ANAVEX®2-73 (blarcamesine) Receives Compassionate Use Authorization for Pediatric Patients with Rett Syndrome - Anavex Life Sciences (NASDAQ:AVXL)

Health Canada Special Access Program (SAP) Authorizes ANAVEX®2-73 (blarcamesine) for patients after successful completion of Open-Label Extension (OLE) study Granting of requests are also ongoing in United Kingdom
United Kingdom Christopheru Missling Andrewj Barwicki Sabrina Millson Access Program Ontario Rett Syndrome Association

ANAVEX®2-73 (blarcamesine) Receives Compassionate Use Authorization for Pediatric Patients with Rett Syndrome

Health Canada Special Access Program Authorizes ANAVEX®2-73 for patients after successful completion of Open-Label Extension study Granting of requests are also ongoing in United Kingdom and... | June 15, 2023
United Kingdom Sabrina Millson Christopheru Missling Andrewj Barwicki Research Business Development Ontario Rett Syndrome Association

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science